This month Total Orphan Drugs is taking a look at clinical trials within the orphan drug space. We will be looking at the current state of trial design, challenges to implementing rare disease trials, as well as a glance towards the future of clinical trials for orphan drugs.
This week we have put together an infographic providing information about the clinical trial process, as well as a few facts and figures unique to rare disease clinical trials.
What are you’re thoughts on clinical trials within the orphan drug sector? Let us now by commenting below, or chatting with us via email.